AdobeStock_303528904

NICE CKD guideline

By

Covering the assessment and management of chronic kidney disease, including pharmacotherapy

AdobeStock_218418521

NICE CKD and anaemia guideline

By

Covering the assessment and management of anaemia in people with chronic kidney disease

Educational resources

22-BM-330474 Index image

Anticoagulation management for elderly patients with NVAF, CKD and other comorbidities

Developed and funded by the Bristol Myers Squibb/Pfizer Alliance

This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting

Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com  or 0800 731 1736 (UK).

432-GB-2200204  May 2022